Zou, Ping

Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells. [electronic resource] - Journal of virology Sep 2007 - 10029-36 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Intramural

0022-538X

10.1128/JVI.02241-06 doi


Animals
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Baculoviral IAP Repeat-Containing 3 Protein
Boronic Acids--pharmacology
Bortezomib
Burkitt Lymphoma--drug therapy
Caspase 8--metabolism
Caspase 9--metabolism
Cell Line, Tumor
Cell Transformation, Viral--drug effects
Herpesvirus 4, Human--metabolism
Humans
Inhibitor of Apoptosis Proteins--metabolism
Mice
Mice, SCID
Multiple Myeloma--drug therapy
NF-kappa B p50 Subunit--metabolism
Proteasome Endopeptidase Complex--metabolism
Proteasome Inhibitors
Proto-Oncogene Proteins c-bcl-2--metabolism
Pyrazines--pharmacology
Signal Transduction--drug effects
Transcription Factor RelA--metabolism
Ubiquitin-Protein Ligases
Viral Matrix Proteins--metabolism
Virus Latency--drug effects
X-Linked Inhibitor of Apoptosis Protein--metabolism
Xenograft Model Antitumor Assays
bcl-X Protein--metabolism